Guilherme S. Caleffi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Guilherme S. Caleffi has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Paulo Roberto Ribeiro Costa
Laboratório de Química Bioorgânica (LQB), Instituto de Pesquisa de Produtos Naturais Walter Mors, Universidade Federal do Rio de Janeiro, 21941-902, Rio de Janeiro, Brazil
11 shared publications - Clarissa Piccinin Frizzo
Federal University of Santa Maria
4 shared publications - Maria Auxiliadora Parreiras Martins
Federal University of Santa Maria (UFSM)
4 shared publications - Felipe Cerqueira Demidoff
Instituto Multidisciplinar de Química Universidade Federal do Rio de Janeiro Macaé Rio de Janeiro 27930‐560 Brazil
3 shared publications - Helio Gauze Bonacorso
Núcleo de Química de Heterociclos (NUQUIMHE), Department of Chemistry, Federal University of Santa Maria (UFSM), 97105-900, Santa Maria, RS, Brazil
3 shared publications - Carmen Nájera
Centro de Innovación en Química Avanzada (ORFEO-CINQA), Universidad de Alicante, Apdo. 99, E-03080 Alicante, Spain
2 shared publications
Latest Publications
- 1 January 2026
- Published by Sociedade Brasileira de Quimica (SBQ) in Journal of the Brazilian Chemical Society
Concise Enantioselective Synthesis of the Antimitotic (+)-2,3,9-Trimethoxypterocarpan via Asymmetric Transfer Hydrogenation
(+)-2,3,9-Trimethoxypterocarpan [(+)-PTC] is a naturally occurring isoflavonoid that exhibits potent antitumor activity, putatively acting through the inhibition of kinesin-5 (Eg5), a mechanism distinct from classic tubulin-targeting agents. However, its preclinical development has been severely hampered by supply limitations, as previous synthetic routes relied on inefficient racemic strategies requiring laborious chiral resolution. Herein, we report a concise, biomimetic, and enantioselective total synthesis of (+)-PTC that overcomes these challenges. The route features a robust ligand-free Suzuki cross-coupling in PEG-400 and utilizes a ruthenium-catalyzed asymmetric transfer hydrogenation coupled with dynamic kinetic resolution (ATH-DKR) as the key stereodefining step. Optimized conditions enabled the scale-up of the key reduction with a low catalyst loading (2 mol%), delivering the pterocarpan core with high optical purity (98% ee) and excellent diastereocontrol. The synthesis was completed in just six steps with 64% overall yield, securing a sustainable supply of the bioactive enantiomer for advanced biological validation and providing divergent access to optically pure isoflavanone analogues.
- 1 January 2026
- Published by Sociedade Brasileira de Quimica (SBQ) in Journal of the Brazilian Chemical Society
Concise Enantioselective Synthesis of the Antimitotic (+)-2,3,9-Trimethoxypterocarpan via Asymmetric Transfer Hydrogenation
(+)-2,3,9-Trimethoxypterocarpan [(+)-PTC] is a naturally occurring isoflavonoid that exhibits potent antitumor activity, putatively acting through the inhibition of kinesin-5 (Eg5), a mechanism distinct from classic tubulin-targeting agents. However, its preclinical development has been severely hampered by supply limitations, as previous synthetic routes relied on inefficient racemic strategies requiring laborious chiral resolution. Herein, we report a concise, biomimetic, and enantioselective total synthesis of (+)-PTC that overcomes these challenges. The route features a robust ligand-free Suzuki cross-coupling in PEG-400 and utilizes a ruthenium-catalyzed asymmetric transfer hydrogenation coupled with dynamic kinetic resolution (ATH-DKR) as the key stereodefining step. Optimized conditions enabled the scale-up of the key reduction with a low catalyst loading (2 mol%), delivering the pterocarpan core with high optical purity (98% ee) and excellent diastereocontrol. The synthesis was completed in just six steps with 64% overall yield, securing a sustainable supply of the bioactive enantiomer for advanced biological validation and providing divergent access to optically pure isoflavanone analogues.
- 23 December 2025
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
- Vol. 13 (4) , 1159-1174
Asymmetric transfer hydrogenation of polyoxygenated 3-arylidenechroman-4-ones: a powerful tool for the total synthesis of natural homoisoflavonoids
A mild and highly efficient one-pot asymmetric transfer hydrogenation (ATH) of challenging, electron-rich 3-arylidenechroman-4-ones is reported.
- 23 December 2025
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
- Vol. 13 (4) , 1159-1174
Asymmetric transfer hydrogenation of polyoxygenated 3-arylidenechroman-4-ones: a powerful tool for the total synthesis of natural homoisoflavonoids
A mild and highly efficient one-pot asymmetric transfer hydrogenation (ATH) of challenging, electron-rich 3-arylidenechroman-4-ones is reported.
- Open Access
- 4 June 2025
- Published by Wiley in ChemMedChem
- Vol. 20 (14) , e202500249
Intracellular and Extracellular Efficacy of Homoisoflavone Derivatives Against Mycobacterium Tuberculosis: Progress Toward Novel Antitubercular Agents
Tuberculosis (TB) remains a leading cause of death among infectious diseases globally, necessitating new drug discovery due to rising drug‐resistant strains. Homoisoflavones, a distinct subgroup of flavonoids characterized by their 3‐benzylidenechroman‐4‐one skeleton, are promising natural products for new antimicrobials. This study explored 42 homoisoflavone derivatives as potential anti‐TB agents. Several derivatives showed potent anti‐Mycobacterium tuberculosis (Mtb) activity. Specifically, derivatives 19, 22, and 41 show good selectivity index and significantly inhibited the Mtb H37Rv strain (MIC90 2.2, 3.8, and 1.9 μM, respectively). Derivatives 22 and 41 were particularly effective against the hypervirulent clinical isolate Mtb M299 (MIC90 1.5 and 2.5 μM, respectively), surpassing the potency of rifampicin (MIC90 3.3 μM). Furthermore, these derivatives inhibited intracellular Mtb H37Rv growth in infected macrophages, with derivative 41 proving most potent (IC50 5.2 μM) due to its unique nitrofuranyl and piperidine groups. The study also established a structure‐activity relationship (SAR) for the homoisoflavone scaffold. In silico analyses suggest these compounds have good oral bioavailability and low toxicity. These findings highlight homoisoflavone derivatives as promising candidates for future anti‐TB drug development.
- 4 June 2025
- Published by Wiley in ChemMedChem
- Vol. 20 (14) , e202500249
Open AccessIntracellular and Extracellular Efficacy of Homoisoflavone Derivatives Against Mycobacterium Tuberculosis: Progress Toward Novel Antitubercular Agents
Tuberculosis (TB) remains a leading cause of death among infectious diseases globally, necessitating new drug discovery due to rising drug‐resistant strains. Homoisoflavones, a distinct subgroup of flavonoids characterized by their 3‐benzylidenechroman‐4‐one skeleton, are promising natural products for new antimicrobials. This study explored 42 homoisoflavone derivatives as potential anti‐TB agents. Several derivatives showed potent anti‐Mycobacterium tuberculosis (Mtb) activity. Specifically, derivatives 19, 22, and 41 show good selectivity index and significantly inhibited the Mtb H37Rv strain (MIC90 2.2, 3.8, and 1.9 μM, respectively). Derivatives 22 and 41 were particularly effective against the hypervirulent clinical isolate Mtb M299 (MIC90 1.5 and 2.5 μM, respectively), surpassing the potency of rifampicin (MIC90 3.3 μM). Furthermore, these derivatives inhibited intracellular Mtb H37Rv growth in infected macrophages, with derivative 41 proving most potent (IC50 5.2 μM) due to its unique nitrofuranyl and piperidine groups. The study also established a structure‐activity relationship (SAR) for the homoisoflavone scaffold. In silico analyses suggest these compounds have good oral bioavailability and low toxicity. These findings highlight homoisoflavone derivatives as promising candidates for future anti‐TB drug development.
- Open Access
- 20 December 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (24) , 13659
Alkaloids from Waltheria spp. (Malvaceae): Chemosystematic Aspects, Biosynthesis, Total Synthesis, and Biological Activities
Waltheria, a genus within the Malvaceae family, is abundantly distributed in tropical and subtropical areas worldwide. Many species of this genus are widely utilized in various ways, including chewing, in folk medicine, acting as an anti-inflammatory agent, and treating gastrointestinal disorders, rheumatism, and asthma, among other conditions. These applications are largely due to their secondary metabolites, primarily quinolone alkaloids and cyclopeptides. Several biological activities have been reported for Waltheria species, including antifungal, anticancer, trypanocidal, acetylcholinesterase inhibitory, potential anti-HIV, antinociceptive, analgesic, anti-inflammatory, antibacterial, antioxidant, and leishmanicidal activities. This review not only presents information on isolated alkaloids and their biological activities but also delves into biosynthetic, chemosystematic, medicinal chemistry, and total synthesis aspects. Additionally, the manuscript highlights other applications of alkaloids of the genus, such as a study on their herbicidal activity, which shows significant potential for agricultural use.
- 20 December 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (24) , 13659
Open AccessAlkaloids from Waltheria spp. (Malvaceae): Chemosystematic Aspects, Biosynthesis, Total Synthesis, and Biological Activities
Waltheria, a genus within the Malvaceae family, is abundantly distributed in tropical and subtropical areas worldwide. Many species of this genus are widely utilized in various ways, including chewing, in folk medicine, acting as an anti-inflammatory agent, and treating gastrointestinal disorders, rheumatism, and asthma, among other conditions. These applications are largely due to their secondary metabolites, primarily quinolone alkaloids and cyclopeptides. Several biological activities have been reported for Waltheria species, including antifungal, anticancer, trypanocidal, acetylcholinesterase inhibitory, potential anti-HIV, antinociceptive, analgesic, anti-inflammatory, antibacterial, antioxidant, and leishmanicidal activities. This review not only presents information on isolated alkaloids and their biological activities but also delves into biosynthetic, chemosystematic, medicinal chemistry, and total synthesis aspects. Additionally, the manuscript highlights other applications of alkaloids of the genus, such as a study on their herbicidal activity, which shows significant potential for agricultural use.
- Open Access
Ru(II)-Catalyzed Asymmetric Transfer Hydrogenation of α-Alkyl-β-Ketoaldehydes via Dynamic Kinetic Resolution
The (R,R)-Teth-TsDPEN-Ru(II) complex promoted the one-pot double C=O reduction of α-alkyl-β-ketoaldehydes through asymmetric transfer hydrogenation/dynamic kinetic resolution (ATH-DKR) under mild conditions. In this process, ten anti-2-benzyl-1-phenylpropane-1,3-diols (85:15 to 92:8 dr) were obtained in good yields (41–87%) and excellent enantioselectivities (>99% ee for all compounds). Notably, the preferential reduction of the aldehyde moiety led to the in situ formation of 2-benzyl-3-hydroxy-1-phenylpropan-1-one intermediates. These intermediates played a crucial role in enhancing both reactivity and stereoselectivity through hydrogen bonding.
Open AccessRu(II)-Catalyzed Asymmetric Transfer Hydrogenation of α-Alkyl-β-Ketoaldehydes via Dynamic Kinetic Resolution
The (R,R)-Teth-TsDPEN-Ru(II) complex promoted the one-pot double C=O reduction of α-alkyl-β-ketoaldehydes through asymmetric transfer hydrogenation/dynamic kinetic resolution (ATH-DKR) under mild conditions. In this process, ten anti-2-benzyl-1-phenylpropane-1,3-diols (85:15 to 92:8 dr) were obtained in good yields (41–87%) and excellent enantioselectivities (>99% ee for all compounds). Notably, the preferential reduction of the aldehyde moiety led to the in situ formation of 2-benzyl-3-hydroxy-1-phenylpropan-1-one intermediates. These intermediates played a crucial role in enhancing both reactivity and stereoselectivity through hydrogen bonding.
- 29 May 2024
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 22 (24) , 4839-4863
Advances in the synthesis of rearranged homoisoflavonoids
This review examines the progress in the total syntheses of these unique complex structures, highlighting their challenges and opportunities.
- 29 May 2024
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 22 (24) , 4839-4863
Advances in the synthesis of rearranged homoisoflavonoids
This review examines the progress in the total syntheses of these unique complex structures, highlighting their challenges and opportunities.
- 1 January 2024
- Published by Sociedade Brasileira de Quimica (SBQ) in Journal of the Brazilian Chemical Society
- Vol. 35 (10)
Flavonoids as Inspiration for the Design and Synthesis of New Antiproliferative, Antiparasitic and Antiviral Compounds: An Account
Modified flavonoids of the sub-group of pterocarpans, 5-carba-pterocarpans, 5-carbapterocarpens, 1-carba-isoflavanones, coumestans, and aurones were synthesized and evaluated as antiproliferative, antileishmanial and antiviral. A new scaffold, called pterocarpanquinone, was discovered and LQB-118, the prototypical scaffold of its series, showed consistent antileishmanial (mice and hamster in vivo) and antineoplastic (respectively, human and mice tumors ex vivo and in vivo) activity. 5-Carpa-pterocarpan LQB-485 is potent towards SF-295 cancer cells (CNS). LQB-262 and LQB-34 are new inhibitors of NB5S RdRp polymerase of hepatitis C virus (HCV) while LQB-314 and LQB-360 demonstrated potent activity and selectivity against HCV replicon reporter cells. LQB-454 and LQB-501 were evaluated for their in vitro anti-proliferative effects against human breast cancer and leukemia cell lines with diverse profiles of drug resistance. In breast cancer they present higher toxicity on multidrug resistant cells (collateral sensitivity). Aurone LQB-814, featuring a “lipophilic phenol” at A-ring”, was a very potent and selective inhibitor of SARS-CoV-2 in Calu-3 cells. Other four aurones bearing EC50 (concentration required to inhibit 50% of cell growth) < 1 were also discovered.
- 1 January 2024
- Published by Sociedade Brasileira de Quimica (SBQ) in Journal of the Brazilian Chemical Society
- Vol. 35 (10)
Flavonoids as Inspiration for the Design and Synthesis of New Antiproliferative, Antiparasitic and Antiviral Compounds: An Account
Modified flavonoids of the sub-group of pterocarpans, 5-carba-pterocarpans, 5-carbapterocarpens, 1-carba-isoflavanones, coumestans, and aurones were synthesized and evaluated as antiproliferative, antileishmanial and antiviral. A new scaffold, called pterocarpanquinone, was discovered and LQB-118, the prototypical scaffold of its series, showed consistent antileishmanial (mice and hamster in vivo) and antineoplastic (respectively, human and mice tumors ex vivo and in vivo) activity. 5-Carpa-pterocarpan LQB-485 is potent towards SF-295 cancer cells (CNS). LQB-262 and LQB-34 are new inhibitors of NB5S RdRp polymerase of hepatitis C virus (HCV) while LQB-314 and LQB-360 demonstrated potent activity and selectivity against HCV replicon reporter cells. LQB-454 and LQB-501 were evaluated for their in vitro anti-proliferative effects against human breast cancer and leukemia cell lines with diverse profiles of drug resistance. In breast cancer they present higher toxicity on multidrug resistant cells (collateral sensitivity). Aurone LQB-814, featuring a “lipophilic phenol” at A-ring”, was a very potent and selective inhibitor of SARS-CoV-2 in Calu-3 cells. Other four aurones bearing EC50 (concentration required to inhibit 50% of cell growth) < 1 were also discovered.
- 31 May 2023
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 86 (6) , 1536-1549
Aurones: A Promising Scaffold to Inhibit SARS-CoV-2 Replication
Aurones are a small subgroup of flavonoids in which the basic C6-C3-C6 skeleton is arranged as (Z)-2-benzylidenebenzofuran-3(2H)-one. These compounds are structural isomers of flavones and flavonols, natural products reported as potent inhibitors of SARS-CoV-2 replication. Herein, we report the design, synthesis, and anti-SARS-CoV-2 activity of a series of 25 aurones bearing different oxygenated groups (OH, OCH3, OCH2OCH3, OCH2O, OCF2H, and OCH2C6H4R) at the A- and/or B-rings using cell-based screening assays. We observed that 12 of the 25 compounds exhibit EC50 < 3 μM (8e, 8h, 8j, 8k, 8l, 8m, 8p, 8q, 8r, 8w, 8x, and 8y), of which five presented EC50 < 1 μM (8h, 8m, 8p, 8q, and 8w) without evident cytotoxic effect in Calu-3 cells. The substitution of the A- and/or B-ring with OCH3, OCH2OCH3, and OCF2H groups seems beneficial for the antiviral activity, while the corresponding phenolic derivatives showed a significant decrease in the anti-SARS-CoV-2 activity. The most potent compound of the series, aurone 8q (EC50 = 0.4 μM, SI = 2441.3), is 2 to 3 times more effective than the polyphenolic flavonoids myricetin (2) and baicalein (1), respectively. Investigation of the five more active compounds as inhibitors of SARS-CoV-2 3CLpro based on molecular dynamic calculations suggested that these aurones should detach from the active site of 3CLpro, and, probably, they could bind to another SARS-CoV-2 protein target (either receptor or enzyme).
- 31 May 2023
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 86 (6) , 1536-1549
Aurones: A Promising Scaffold to Inhibit SARS-CoV-2 Replication
Aurones are a small subgroup of flavonoids in which the basic C6-C3-C6 skeleton is arranged as (Z)-2-benzylidenebenzofuran-3(2H)-one. These compounds are structural isomers of flavones and flavonols, natural products reported as potent inhibitors of SARS-CoV-2 replication. Herein, we report the design, synthesis, and anti-SARS-CoV-2 activity of a series of 25 aurones bearing different oxygenated groups (OH, OCH3, OCH2OCH3, OCH2O, OCF2H, and OCH2C6H4R) at the A- and/or B-rings using cell-based screening assays. We observed that 12 of the 25 compounds exhibit EC50 < 3 μM (8e, 8h, 8j, 8k, 8l, 8m, 8p, 8q, 8r, 8w, 8x, and 8y), of which five presented EC50 < 1 μM (8h, 8m, 8p, 8q, and 8w) without evident cytotoxic effect in Calu-3 cells. The substitution of the A- and/or B-ring with OCH3, OCH2OCH3, and OCF2H groups seems beneficial for the antiviral activity, while the corresponding phenolic derivatives showed a significant decrease in the anti-SARS-CoV-2 activity. The most potent compound of the series, aurone 8q (EC50 = 0.4 μM, SI = 2441.3), is 2 to 3 times more effective than the polyphenolic flavonoids myricetin (2) and baicalein (1), respectively. Investigation of the five more active compounds as inhibitors of SARS-CoV-2 3CLpro based on molecular dynamic calculations suggested that these aurones should detach from the active site of 3CLpro, and, probably, they could bind to another SARS-CoV-2 protein target (either receptor or enzyme).
- 17 October 2022
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 87 (21) , 14208-14222
Ru(II)-Catalyzed Asymmetric Transfer Hydrogenation of Chalcones in Water: Application to the Enantioselective Synthesis of Flavans BW683C and Tephrowatsin E
The oxo-tethered-Ru(II) precatalyst promoted the one-pot C═C/C═O reduction of chalcones using sodium formate as the hydrogen source in water through asymmetric transfer hydrogenation. Twenty-seven 1,3-diarylpropan-1-ols were obtained in good to excellent yields (up to 96%) and enantiomeric purities (up to 98:2). Our data suggested that the enones are first reduced to the corresponding dihydrochalcones (1,4-selectivity) and then into 1,3-diarylpropan-1-ols (C═O reduction). The stereoelectronic effects of electron-donating and electron-withdrawing groups at the ortho, meta and para positions of both aromatic rings were evaluated. The 2-OH group at the B ring was well tolerated, allowing a straightforward enantioselective synthesis of two flavans through the Mitsunobu cyclization, the antiviral (S)-BW683C and the natural flavan (S)-tephrowatsin E.
- 17 October 2022
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 87 (21) , 14208-14222
Ru(II)-Catalyzed Asymmetric Transfer Hydrogenation of Chalcones in Water: Application to the Enantioselective Synthesis of Flavans BW683C and Tephrowatsin E
The oxo-tethered-Ru(II) precatalyst promoted the one-pot C═C/C═O reduction of chalcones using sodium formate as the hydrogen source in water through asymmetric transfer hydrogenation. Twenty-seven 1,3-diarylpropan-1-ols were obtained in good to excellent yields (up to 96%) and enantiomeric purities (up to 98:2). Our data suggested that the enones are first reduced to the corresponding dihydrochalcones (1,4-selectivity) and then into 1,3-diarylpropan-1-ols (C═O reduction). The stereoelectronic effects of electron-donating and electron-withdrawing groups at the ortho, meta and para positions of both aromatic rings were evaluated. The 2-OH group at the B ring was well tolerated, allowing a straightforward enantioselective synthesis of two flavans through the Mitsunobu cyclization, the antiviral (S)-BW683C and the natural flavan (S)-tephrowatsin E.
- 30 November 2021
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
- Vol. 9 (4) , 1165-1194
Asymmetric hydrogenation and transfer hydrogenation in the enantioselective synthesis of flavonoids
In this review, we explore the applications of Asymmetric Hydrogenation (AH) and Asymmetric Transfer Hydrogenation (ATH) in the total synthesis of natural flavonoids and their analogues, highlighting the limitations and opportunities in the field.
- 30 November 2021
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
- Vol. 9 (4) , 1165-1194
Asymmetric hydrogenation and transfer hydrogenation in the enantioselective synthesis of flavonoids
In this review, we explore the applications of Asymmetric Hydrogenation (AH) and Asymmetric Transfer Hydrogenation (ATH) in the total synthesis of natural flavonoids and their analogues, highlighting the limitations and opportunities in the field.